Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer

de Heer, EC; Zois, CE; Bridges, E; van der Vegt, B; Sheldon, H; Veldman, WA; Zwager, MC; van der Sluis, T; Haider, S; Morita, T; Baba, O; Schröder, CP; de Jong, S; Harris, AL; Jalving, M

Jalving, M (通讯作者),Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, POB 30-001, NL-9700 RB Groningen, Netherlands.;Zois, CE (通讯作者),Univ Oxford, Weatherall Inst Mol Med, Dept Oncol, Canc Res UK Mol Oncol Labs,Hypoxia & Angiogenesis, Oxford OX3 9DS, England.;Zois, CE (通讯作者),Democritus Univ Thrace, Sch Hlth, Dept Radiotherapy & Oncol, Alexandroupolis, Greece.;Zois, CE (通讯作者),Univ Oxford, Dept Oncol, MRC Weatherall Inst Mol Med, John Radcliffe Hosp,Mol Oncol Labs, Oxford OX3 9DS, England.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023; 42 (1):

Abstract

BackgroundHypoxia-induced glycogen turnover is implicated in cancer proliferation and therapy resistance. Triple-negative breast cancers (TNBCs), char......

Full Text Link